94 related articles for article (PubMed ID: 15208585)
1. Response to inhaled albuterol during nocturnal asthma.
Hendeles L; Beaty R; Ahrens R; Stevens G; Harman EM
J Allergy Clin Immunol; 2004 Jun; 113(6):1058-62. PubMed ID: 15208585
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma.
Rodrigo GJ; Rodrigo C
Emerg Med J; 2005 Jun; 22(6):404-8. PubMed ID: 15911945
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
7. Response to nonprescription epinephrine inhaler during nocturnal asthma.
Hendeles L; Marshik PL; Ahrens R; Kifle Y; Shuster J
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):530-4. PubMed ID: 16400891
[TBL] [Abstract][Full Text] [Related]
8. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
9. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Duarte AG; Momii K; Bidani A
Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
[TBL] [Abstract][Full Text] [Related]
12. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
13. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
14. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
15. [High-dose inhaled beta-2 sympathomimetics in severe bronchial asthma].
Meyer A; Jacobsen P; Magnussen H
Pneumologie; 1990 Feb; 44 Suppl 1():236-7. PubMed ID: 2367376
[TBL] [Abstract][Full Text] [Related]
16. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
Raissy HH; Harkins M; Kelly F; Kelly HW
Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
19. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
[TBL] [Abstract][Full Text] [Related]
20. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]